{"url_path":"/sec/rtgn/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-033369-index.html","accession_number":"0001493152-26-033369","cik":"0001836295","ticker":"RTGN","issuer_name":"RetinalGenix Technologies Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1836295/0001493152-26-033369-index.html","primary_entity_key":"0001836295","primary_entity_name":"RetinalGenix Technologies Inc."},"word_count":79,"has_tables":true,"body_markdown":"**Item\n9.01 Financial Statements and Exhibits.**\n\n \n\n(d)\nExhibits.\n\n \n\n**Exhibit\nNo.**\n \n**Description**\n\n16.1\n \n[Letter from Liebman Hymowitz, LLP addressed to the Securities and Exchange Commission.](ex16-1.htm)\n\n104\n \nCover\nPage Interactive Data File.\n\n \n\n-3-\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \n**RETINALGENIX\nTECHNOLOGIES INC.**\n\n \n \n \n\nDate:\nJuly 15, 2026\nBy:\n*/s/\nJerry Katzman*\n\n \n \n\nJerry\nKatzman\n\nChief\nExecutive Officer\n\n \n\n-4-"}